Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $694 Million of Initial Proceeds
11 Maio 2023 - 11:13PM
Business Wire
Transaction Highlights
- Walgreens Boots Alliance announces the sale of shares of
AmerisourceBergen Corporation pursuant to variable prepaid forward
transactions executed in reliance on Rule 144 for current proceeds
of approximately $644 million and, depending on the stock price at
the time, potentially additional proceeds at maturity, along with a
concurrent share repurchase by AmerisourceBergen of approximately
$50 million
- Variable prepaid forward transactions provide liquidity while
maintaining ability to participate in potential stock price
appreciation
- Proceeds to Walgreens Boots Alliance will be used primarily for
debt paydown and general corporate purposes
- No changes to ongoing collaboration and long-term strategic
partnership
- Variable prepaid forward transactions provide no dilutive
impact on Walgreens Boots Alliance’s adjusted EPS from the sale
until the contracts mature in the fourth quarter of fiscal year
2025
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced
that it has sold shares of AmerisourceBergen Corporation (NYSE:
ABC) (“AmerisourceBergen”) common stock pursuant to variable
prepaid forward transactions executed in reliance on Rule 144 of
the Securities Act of 1933, as amended, for current proceeds of
approximately $644 million. In addition, and subject to the closing
of the Rule 144 transaction, Walgreens Boots Alliance entered into
a concurrent share repurchase by AmerisourceBergen for proceeds of
approximately $50 million.
Walgreens Boots Alliance’s ownership of AmerisourceBergen’s
common stock has decreased as a result of the concurrent share
repurchase by AmerisourceBergen but remains at approximately
17%.
Walgreens Boots Alliance’s ownership of AmerisourceBergen’s
common stock has not been impacted by the entry into the variable
prepaid forward transactions. The entry into the variable prepaid
forward contracts provides Walgreens Boots Alliance with current
liquidity while allowing it to maintain voting and dividend rights
in the AmerisourceBergen common stock, as well as the ability to
participate in potential stock price appreciation during the term
of the contracts. The contracts are scheduled to settle starting in
the fourth quarter of fiscal year 2025, at which time Walgreens
Boots Alliance intends to deliver 4,590,000 shares of
AmerisourceBergen common stock in the aggregate to the
counterparties to the contracts, and may receive additional
proceeds up to $204 million depending on the stock price at the
time.
Proceeds to Walgreens Boots Alliance will be used primarily for
debt paydown and general corporate purposes.
The sale has no impact on the long-term partnership between the
two companies. Walgreens Boots Alliance remains fully committed to
the strategic, mutually beneficial relationship with
AmerisourceBergen, which has been a strong and trusted partner
since 2013. Chief Operating Officer, International of Walgreens
Boots Alliance, Ornella Barra, will continue to serve on
AmerisourceBergen’s Board of Directors.
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is an integrated
healthcare, pharmacy and retail leader serving millions of
customers and patients every day, with a 170-year heritage of
caring for communities.
A trusted, global innovator in retail pharmacy with
approximately 13,000 locations across the U.S., Europe and Latin
America, WBA plays a critical role in the healthcare ecosystem. The
company is reimagining local healthcare and well-being for all as
part of its purpose – to create more joyful lives through better
health. Through dispensing medicines, improving access to a wide
range of health services, providing high quality health and beauty
products and offering anytime, anywhere convenience across its
digital platforms, WBA is shaping the future of healthcare.
WBA employs more than 325,000 people and has a presence in nine
countries through its portfolio of consumer brands: Walgreens,
Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico and
Ahumada in Chile. Additionally, WBA has a portfolio of
healthcare-focused investments located in several countries,
including China and the U.S.
The company is proud of its contributions to healthy
communities, a healthy planet, an inclusive workplace and a
sustainable marketplace. WBA has been recognized for its commitment
to operating sustainably: the company is an index component of the
Dow Jones Sustainability Indices (DJSI) and was named to the 100
Best Corporate Citizens 2022.
WBA-GEN
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230511006012/en/
WBA Media Relations USA / Jim Cohn, +1 224 813 9057
International, +44 (0)20 7980 8585
WBA Investor Relations Tiffany Kanaga, +1 847 315
2922
Walgreens Boots Alliance (NASDAQ:WBA)
Gráfico Histórico do Ativo
De Ago 2023 até Set 2023
Walgreens Boots Alliance (NASDAQ:WBA)
Gráfico Histórico do Ativo
De Set 2022 até Set 2023